Extranet 
Welcome to SAFC Pharma
 

Viral Vaccines & Therapeutics

Complex Emerging Technologies

Virus Manufacturing Image
Development and cGMP Manufacturing of
Viral Vaccines & Therapeutics

SAFC Pharma provides over 10 years experience in manufacturing viral vectors and vaccines with highly trained personnel and state-of-the-art facilities. Recently announced, the expanded analytical and manufacturing capabilities now support customers from pre-clinical to commercial-scale quantities.
Our Offer
  Process development
  cGMP manufacturing of clinical drug and commercial products
  Final fill/finish
  Regulatory compliance services
Vaccines Development & Manufacturing
  Vaccines have undergone a renaissance in the past decade as new manufacturing techniques and new indications have spurred investment into next-generation candidates. SAFC Pharma has experience working with small and large biotechs for such indications as influenza, pandemic flu, AIDS, malaria and other vaccines.
Therapeutics Development & Manufacturing
  While most indications now revolve around oncology, SAFC Pharma has supported gene therapy clients for over 10 years and products for all major viral vector systems and many clinical trials.
Service Offering Examples
  cGMP Viral Bulk Drug Substance Manufacturing
  cGMP Cell and Viral Banking
  Sterile Fill and Finish
  Secure Biostorage
  Containment facility
  Access to fully characterized 293-clonal cell line (AC2)
  Access to PER.C6™ cell line*
QC and Analytical Services
SAFC Pharma provides customers with complete support, including the development of specifications, risk assessment, implementation of process controls and qualified disinfectant cleaning procedures.

In addition to our state-of-the-art PCR facility we offer:
  Phase-specific analytical development
  Characterization, certification and control of all incoming raw materials
  QC testing of in-process materials
  Release testing as requested
  Stability studies

With extensive experience in process development, our chemists prepare bench-scale processes for development to
Phase I production using capabilities in:
  Vector construction
  Characterization studies
  Media development (through respected sister company, SAFC Biosciences™)
Traditional or Disposable Bioreactor Selection
  Wave
  Single Use Bioreactor (SUB)
  Upstream and downstream process improvements that can increase yield
  Stir-Tank
  Shake Flasks
Quality Management
  Independent Quality Assurance (QA) unit
  Highly experienced staff
  Clinical product successfully manufactured for trials in US, EU and Asia
  Rigorous compliance program
Project Management
  SAFC's Project Managers lead multi-functional teams in support of custom cGMP projects and serve as single-point-of-contact for customers to facilitate timely communication of important technical information and production timelines.

Request Information

* PER.C6 cells are manufactured under license to Crucell, N.V.
Commercial clients must have a separate research and/or commercial license from Crucell, N.V. PER.C6 cells are available for academic and governmental clients through payment of project specific access fees.